Layton JB, Anderson-Smits C, Huang Z, Ay H, Spalding W, Khokhar B, Zhou J, Bennett L, Anthony M. A comparative real-world study evaluating the safety of gammagard liquid and other intravenous immunoglobulin therapies for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Poster presented at the 2023 AANEM Annual Meeting; November 2023. Phoenix, AZ.
Anderson-Smits C, Ritchey ME, Huang Z, Chavan S, Souayah N, Ay H, Layton BJ. Intravenous immunoglobulin treatment patterns and outcomes in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a US claims database analysis. Neurol Ther. 2023 Aug;12(4):1119-32. doi: 10.1007/s40120-023-00478-5
Layton JB, Ritchey ME, Huang Z, Chavan S, Ay H, Souayah N, Anderson-Smits C. Intravenous immunoglobulin initiation in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a US claims-based cohort study. Neurol Ther. 2023 Aug;12(4):1171-86. doi: 10.1007/s40120-023-00479-4
Anderson-Smits C, Orange J, Park M, Huang Z, Layton JB, Ritchey ME. Immunoglobulin initiation among patients with primary immunodeficiency diseases: a retrospective claims-based United States cohort study. Presented at the AMCP 2022 Meeting; March 29, 2022. Chicago, IL.
Anderson-Smits C, Layton JB, Ritchey ME, Hayden V, Chavan S, Souayah N. Intravenous immunoglobulin initiation in chronic inflammatory demyelinating polyradiculoneuropathy: a retrospective claims-based cohort study. Poster presented at the 2021 American Association of Neuromuscular & Electrodiagnostic Medicine Conference; October 2021. Aurora, CO. Previously presented at the 2021 Peripheral Nerve Society Virtual Meeting.
Anderson-Smits C, Layton JB, Ritchey ME, Chavan S, Souayah N. Intravenous immunoglobulin treatment patterns in chronic inflammatory demyelinating polyradiculoneuropathy patients: a US claims database analysis. Poster presented at the 2021 Peripheral Nerve Society Virtual Meeting; June 12, 2021.
Anderson-Smits C, Layton JB, Ritchey ME, Hayden V, Chavan S, Souayah N. Intravenous immunoglobulin initiation in chronic inflammatory demyelinating polyradiculoneuropathy: a retrospective claims-based cohort study. Poster presented at the 2021 Peripheral Nerve Society Virtual Meeting; June 12, 2021.
Anderson-Smits C, Huang Z, Ritchey MB, Layton JB. Procedure coding versus pharmacy-dispensing claims for assessing steroid use in patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Primary Immunodeficiency Diseases (PIDD). Poster presented at the Virtual ISPOR 2021 Conference; May 2021.
Layton JB, Ritchey MB, Huang Z, Anderson-Smits C. Replicating clinical trial exclusion criteria in a claims-based cohort of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) initiating Intravenous Immunoglobulin (IVIG) treatment. Poster presented at the Virtual ISPOR 2021 Conference; May 2021.
Anderson-Smits C, Layton JB, Ritchey ME, Hayden V, Chavan S, Souayah N. Patient and treatment characteristics of a large US sample of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Initiating Intravenous Immunoglobulin (IVIG) therapy. Poster presented at the American Academy of Neurology (AAN) 2021 Virtual Annual Meeting; April 17, 2021. Previously presented at the 2020 Muscle Study Group (MSG) Annual Virtual Meeting.
Anderson-Smits C, Orange J, Park M, Huang Z, Layton JB, Ritchey ME. Immunoglobulin initiation among patients with Primary Immunodeficiency Diseases (PIDD): a retrospective claims-based US cohort study. Poster presented at the 2021 Clinical Immunology Society (CIS) Virtual Meeting; April 14, 2021.
Anderson-Smits C, Layton JB, Ritchey ME, Hayden V, Chavan S, Souayah N. Patient and treatment characteristics of a large US sample of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Initiating Intravenous Immunoglobulin (IVIG) therapy. Poster presented at the IgNS Virtual 2020 9th National Conference; October 22, 2020.
Layton JB, Anderson-Smits C, Ritchey ME, Chavan S, Souayah N. Treatment patterns of US patients with chronic inflammatory demyelinating polyradiculoneuropathy. Poster presented at the 2020 Virtual American Association of Neuromuscular and Electrodiagnostic Medicine Annual Meeting; October 2020. [abstract] Muscle Nerve. 2020 Oct; p.126.
Layton JB, Ritchey ME, Huang Z, Anderson-Smits C. Comparability of patients with CIDP using intravenous immunoglobulin in Medicaid vs commercial or Medicare claims data. Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.
Layton JB, Ritchey ME, Huang Z, Anderson-Smits C, Hill G. Identifying immunoglobulin use in claims data with procedure coding and pharmacy dispensing data. Poster presented at the 2020 36th ICPE International Virtual Conference on Pharmacoepidemiology & Therapeutic Risk Management; September 16, 2020.
Anderson-Smits C, Layton JB, Ritchey ME, Hayden V, Chavan S, Souayah N. Patient and treatment characteristics of a large US sample of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) initiating Intravenous Immunoglobulin (IVIG) therapy. Poster presented at the 2020 Muscle Study Group (MSG) Annual Virtual Meeting; September 25, 2020. [abstract] RRNMF Neu J. 2020 Sep; 1(4):61.
Layton JB, Anderson-Smits C, Ritchey ME, Chavan S, Souayah N. Treatment patterns of a large US sample of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) patients. Poster presented at the 2020 6th EAN Congress Virtual Congress; May 23, 2020.
Anderson-Smits C, Layton JB, Ritchey ME, Hayden V, Sehinovych I, Chavan S, Souayah N. Patient and treatment characteristics of a large US sample of patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) initiating Intravenous Immunoglobulin (IVIG) therapy. Poster presented at the 2020 Virtual American Academy of Neurology Annual Meeting (Conference cancelled); April 25, 2020. Toronto, Canada. [abstract] Neurology. 2020 Apr 14; 94(15 Supplement):4442.